126
Views
8
CrossRef citations to date
0
Altmetric
Review

Thin-film technology for direct visual detection of nucleic acid sequences: applications in clinical research

, , &
Pages 89-99 | Published online: 09 Jan 2014

References

  • Sandstrom T, Stenberg, M, Nygren H. Visual detection of organic monomolecular films by interference colors. Appl. Opt. 24(4), 472–479 (1985).
  • Jenison R, Yang, S, Haeberli, A, Polisky B. Interference-based detection of nucleic acid targets on optically coated silicon. Nature Biotech. 19(1), 62–65 (2001).
  • Ostroff R, Maul D, Baouchi W. Thin film biosensors. Vac. Thinfilm 30–33 (1999).
  • Harbeck RJ, Teague J, Crossen GR, Maul DM, Childers PL. Novel, rapid optical immunoassay technique for detection of group A streptococci from pharyngeal specimens: comparison with standard culture methods. J. Clin. Microbiol. 31(4), 839–844 (1993).
  • Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 288(10), 498–505 (1973).
  • Fan J, Henrickson KJ, Savatski LL. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-ennzyme hybridization assay (Hexaplex). Clin. Infect. Dis. 26(6), 1397–1402 (1998).
  • Whimbey E, Englund JA, Ljungman P. Proceedings of a symposium: community respiratory infections in the immunocompromised host. Am. J. Med. 102(3A), 1–86 (1997).
  • Weinstein P. Planning for epidemics – the lessons of SARS. N. Engl. J. Med. 350, 2332–2334 (2004).
  • Ungchusak K, Auewarakul P, Dowell SF et al. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352(4), 333–340 (2005).
  • Grohndahl B, Puppe W, Hoppe A, Kuhne I, Weigl JAI, Schmitt HJ. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study. J. Clin. Microbiol. 37(1), 1–7 (1999).
  • Jenison R, Rihanek M, Polisky B. Use of a thin film biosensor for rapid visual detection of PCR products in a multiplex format. Biosens. Bioelectron. 16(9–12), 757–763 (2001).
  • Roberts RR, Scott RD Jr, Cordell R et al. The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin. Infect. Dis. 36(11), 1424–1432 (2003).
  • Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am. J. Med. 100(6A) 3S–9S (1996).
  • Karchmer AW. Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin. Infect. Dis. 31(S4), S139–S143 (2000).
  • Diekema DJ, Dodgson KJ, Sigurdardottir B, Pfaller MA. Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need. J. Clin. Microbiol. 42(7), 2879–2883 (2004).
  • Fluit AC, Wielders CLC, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J. Clin. Microbiol. 39(10), 3727–3732 (2001).
  • Sabath LD. Mechanisms of resistance to β-lactam antibiotics in strains of Staphylococcus aureus. Ann. Intern. Med. 97(3), 339–344 (1982).
  • Boyce JM, Havill NL, Kohan C, Dumigan DG, Ligi CE. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect. Control Hospit. Epid. 25(5) 395–401 (2004).
  • Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis. 39(6), 776–782 (2004).
  • Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch. Intern. Med. 162(19), 2229–2235 (2003).
  • Jenison R, Haeberli A, Yang S, Polisky B, Ostroff R. Thin film biosensor for rapid detection of mecA from methicillin-resistant Staphylococcus aureus. Clin. Chem. 46(9) 1501–1504 (2000).
  • Doern GV, Vantour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J. Clin. Microbiol. 32(7) 1757–1762 (1994).
  • Majid AM, Gretch DR. Current and future hepatitis C virus diagnostic testing: problems and advancements. Microb. Infect. 4(12), 1227–1236 (2002).
  • Conry-Cantilena C. Hepatitis C virus diagnostics: technology, clinical applications and impacts. Trends Biotechnol. 15(2), 71–76 (1997).
  • Vaish NK, Jadhav VR, Kossen K et al. Zeptomole detection of a viral nucleic acid using a target-activated ribozyme. RNA 9(9), 1058–1072 (2003).
  • Bartel DP, Szostak JW. Isolation of new ribozymes from a large pool of random sequences. Science 261(5127), 1411–1418 (1993).
  • Kossen K, Vaish NK, Jadhav VR et al. High-throughput ribozyme-based assays for detection of viral nucleic acids. Chem. Biol. 11(6), 1–20 (2004).
  • Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F. Single nucleotide polymorphism seeking long-term association with complex disease. Nucleic Acids Res. 30(15), 3295–3311 (2002).
  • Strom CM. Mutation detection, interpretation and applications in the clinical laboratory setting. Mutat. Res. 573(1–2), 160–167 (2005).
  • Richards CS, Grody WW. Prenatal screening for cystic fibrosis: past, present and future. Expert Rev. Mol. Diagn. 4(1) 49–62 (2004).
  • American College of Obstetrics and Gynecology. American College of Obstetrics and American College of Medical Genetics, preconception and prenatal carrier screening for cystic fibrosis, clinical and laboratory guidelines. American College of Obstetrics and Gynecology, DC, USA (2001).
  • Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines for population based cystic fibrosis carrier screening. Genet. Med. 3(2), 149–154 (2001).
  • Kerem BS, Rommens J, Buchanan JA et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245(4922), 1073–1080 (1989).
  • Rommens J, Iannuzzi MC, Kerem BS et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245(4922), 1059–1065 (1989).
  • Riordan JR, Rommens J, Kerem BS et al. Identification of cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922), 1066–1073 (1989).
  • Strom CM, Clark DD, Hantash FM et al. Direct visualization of cystic fibrosis transmembrane regulator mutations in the clinical laboratory setting. Clin. Chem. 50(5), 836–845 (2004).
  • Eaton BE, Gold L, Zichi DA. Let’s get specific: the relationship between specificity and affinity. Chem. Biol. 2(10), 633–638 (1995).
  • Demidov VV, Frank-Kamenetskii MD. Two sides of the coin: affinity and specificity of nucleic acid interactions. Trends Biochem. Sci. 29(2), 62–71 (2004).
  • Zhong X, Reynolds R, Kidd JR et al. Single-nucleotide polymorphism genotyping on optical thin-film biosensor chips. Proc. Natl Acad. Sci. USA 100(20), 11559–11564 (2003).
  • Ridker PM, Hennekens CH, Selhub J et al. Interrelation of hyperhomocyst(e)inemia, Factor V Leiden, and risk of future venous thromboembolism. Circulation 95(7), 1777–1782 (1997).
  • Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin. Hematol. 34(3), 171–187 (1997).
  • Genomics and World Health. Genomics and World Health: Report of the Advisory Committee on Health Research. World Health Organization, Geneva, Switzerland (2002).
  • Bremen J. The ears of the hippopotamus: manifestations, determinants, and the estimate of the malaria burden. Am. J. Trop. Med. Hyg. 64, S1–11 (2001).
  • Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338(10), 640–644 (1998).
  • McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371(6497), 508–511 (1994).
  • Wattavidanage J, Carter R, Perera KL et al. TNF α*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin. Exp. Immunol. 115(2), 350–355 (1999).
  • Koch O, Awomoyi A, Usen S et al. IFN GR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J. Infect. Dis. 185(11), 1684–1687 (2002).
  • Morahan G, Boutlis GS, Huang D et al. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun. 3(7), 414–418 (2002).
  • Lio D, Marino V, Serauto A et al. Genotype frequencies of the +874T→A single nucleotide polymorphism in the first intron of the interferon-β gene in a sample of Sicilian patients affected by tuberculosis. Eur. J. Immunogenet. 29(5), 371–374 (2002).
  • Arora R, Saha A, Malhotra D, Rath P, Kar P, Bamezi R. Promoter and intron-1 region polymorphisms in the IFN α gene in patients with hepatitis E. Int. J. Immunogenet. 32(3), 207–212 (2005).
  • Anastassopoulou CG, Kostrikis LG. The impact of human allelic variation on HIV-1 disease. Curr. HIV Res. 1(2), 185–203 (2003).
  • Gregersen PK, Bucala R. Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum. 48(5), 1171–1176 (2003).
  • Zhong X, Leng L, Beitin A et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res. 33(13), e121 (2005).
  • Dean FB, Hosono S, Fang L et al. Comprehensive human genome amplification using multiple displacement amplification. Proc. Natl Sci. USA 99(8), 5261–5266 (2002).
  • Jenison R, La H, Haeberli A, Ostroff R, Polisky B. Silicon-based biosensors for rapid detection of protein or nucleic acid targets. Clin. Chem. 47(10), 1894–1900 (2001).
  • Read SJ, Kurtz JB. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J. Clin. Microbiol. 37(5), 1352–1355 (1999).
  • Paez JG, Janne PA, Lee JC et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304(5676), 1497–1500 (2004).
  • Demetri GD, von Mehren M, Blanke CD et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347(7), 472–480 (2002).
  • Yates CR, Krynetski EY, Loennechen T et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency. Ann. Intern. Med. 128(8), 608–614 (1997).
  • McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics. Pharmacogenomics J. 3(1), 89–98 (2002).
  • Tanaka E. Update: genetic polymorphism of drug metabolizing enzymes in humans. J. Clin. Pharm. Ther. 24(5), 323–329 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.